Five US states agree to suspend litigation against bankrupt opioid maker Insys — report
While filing for bankruptcy last month, controversial drugmaker Insys sought an injunction against lawsuits alleging the company stoked the opioid crisis. Five states have now reportedly dropped their objections to that request, and agreed to facilitate settlement talks.
Insys’ $INSY bankruptcy filing came days after the company agreed to pay $225 million to settle the US government’s separate criminal and civil investigations related to its spray, Subsys — about a month after its founder and former senior executive team were found guilty by a federal jury of racketeering. Founder John Kapoor and his four compatriots’ antics included bribing doctors to prescribe the potent, addictive painkiller and duping insurers into paying for the deadly opioid drug.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.